Matches in Nanopublications for { ?s ?p "[The frequency and precise loss of CDKN2B(INK4b), CDKN2A(ARF, INK4a), and MTAP in the prognosis of 9p21-deleted HNSCC may provide impetus for use of these targets as therapeutic biomarkers in head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP431834.RACa6gmIPQi9SdRHRtXvKZX7mGxaJGzEY_xvyCz8Q80w8130_assertion description "[The frequency and precise loss of CDKN2B(INK4b), CDKN2A(ARF, INK4a), and MTAP in the prognosis of 9p21-deleted HNSCC may provide impetus for use of these targets as therapeutic biomarkers in head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431834.RACa6gmIPQi9SdRHRtXvKZX7mGxaJGzEY_xvyCz8Q80w8130_provenance.
- NP545308.RAllIVPgd5w84kXU4nh2RZizNT0zRtCLUFd50ClAgC0PI130_assertion description "[The frequency and precise loss of CDKN2B(INK4b), CDKN2A(ARF, INK4a), and MTAP in the prognosis of 9p21-deleted HNSCC may provide impetus for use of these targets as therapeutic biomarkers in head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545308.RAllIVPgd5w84kXU4nh2RZizNT0zRtCLUFd50ClAgC0PI130_provenance.